BAJAJ BROKING

Notification close image
No new Notification messages
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

532041

HINDBIO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

HINDUSTAN BIO SCIENCES LTD. Share Price Update

As of the latest trading session, HINDUSTAN BIO SCIENCES LTD. share price is currently at ₹ 8.17, which is down by ₹ -0.01 from its previous closing. Today, the stock has fluctuated between ₹ 8.01 and ₹ 8.18. Over the past year, HINDUSTAN BIO SCIENCES LTD. has achieved a return of -9.11 %. In the last month alone, the return has been -3.99 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

HINDUSTAN BIO SCIENCES LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    8.40

  • P/E Ratio (TTM)

    272.67

  • Beta

    0.15

  • Book Value / share

    0.88

  • Return on equity

    4.88%

  • EPS (TTM)

    0.03

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.01

info icon alternate text

HINDUSTAN BIO SCIENCES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 0.32
Operating Expense 0.32
Net Profit 0.01
Net Profit Margin (%) 3.12
Earnings Per Share (EPS) 0.01
EBITDA 0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.38
Operating Expense 0.28
Net Profit 0.11
Net Profit Margin (%) 28.94
Earnings Per Share (EPS) 0.11
EBITDA 0.11
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.04
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.05
Net Profit -0.05
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.05
EBITDA -0.05
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.41
Operating Expense 0.34
Net Profit 0.08
Net Profit Margin (%) 19.51
Earnings Per Share (EPS) 0.08
EBITDA 0.08
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.81
Operating Expense 0.71
Net Profit 0.10
Net Profit Margin (%) 12.34
Earnings Per Share (EPS) 0.10
EBITDA 0.10
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 1.03
Operating Expense 1.00
Net Profit 0.06
Net Profit Margin (%) 5.82
Earnings Per Share (EPS) 0.06
EBITDA 0.06
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.92
Operating Expense 0.96
Net Profit -0.04
Net Profit Margin (%) -4.34
Earnings Per Share (EPS) -0.04
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.43
Operating Expense 0.95
Net Profit -0.52
Net Profit Margin (%) -120.93
Earnings Per Share (EPS) -0.50
EBITDA -0.50
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 1.03
Operating Expense 1.99
Net Profit -0.94
Net Profit Margin (%) -91.26
Earnings Per Share (EPS) -0.92
EBITDA -0.94
Effective Tax Rate (%) 2.08
Particulars MAR 2025 (Values in Cr)
Book Value / Share 0.88
ROE % 4.88
ROCE % 2.18
Total Debt to Total Equity 2.98
EBITDA Margin 12.35
Particulars MAR 2024 (Values in Cr)
Book Value / Share 0.78
ROE % 4.29
ROCE % 1.53
Total Debt to Total Equity 3.24
EBITDA Margin 5.71
Particulars MAR 2023 (Values in Cr)
Book Value / Share 3.64
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 3.01
EBITDA Margin -3.26
Particulars MAR 2022 (Values in Cr)
Book Value / Share 0.77
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.93
EBITDA Margin -118.60
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1.27
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.26
EBITDA Margin -91.26
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 3.42
Total Liabilities 3.42
Total Equity 0.90
Share Outstanding 10250800
Price to Book Ratio 7.93
Return on Assets (%) 2.94
Return on Capital (%) 2.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 3.37
Total Liabilities 3.37
Total Equity 0.80
Share Outstanding 10250800
Price to Book Ratio 9.29
Return on Assets (%) 1.70
Return on Capital (%) 1.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 3.28
Total Liabilities 3.28
Total Equity 0.74
Share Outstanding 2050160
Price to Book Ratio 1.46
Return on Assets (%) -1.23
Return on Capital (%) -1.26
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 2.97
Total Liabilities 2.97
Total Equity 0.78
Share Outstanding 10250800
Price to Book Ratio 5.48
Return on Assets (%) -17.39
Return on Capital (%) -17.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 3.48
Total Liabilities 3.48
Total Equity 1.30
Share Outstanding 10250800
Price to Book Ratio 2.36
Return on Assets (%) -26.95
Return on Capital (%) -29.71
Particulars MAR 2025 (Values in Cr)
Net Income 0.09
Cash from Operations 0.02
Cash from Investing 0.00
Cash from Financing -0.05
Net change in Cash -0.02
Free Cash Flow 0.02
Particulars MAR 2024 (Values in Cr)
Net Income 0.05
Cash from Operations -1.40
Cash from Investing 0.00
Cash from Financing 1.43
Net change in Cash 0.02
Free Cash Flow -1.40
Particulars MAR 2023 (Values in Cr)
Net Income -0.03
Cash from Operations -0.04
Cash from Investing 0.00
Cash from Financing 0.05
Net change in Cash 0.00
Free Cash Flow -0.04
Particulars MAR 2022 (Values in Cr)
Net Income -0.51
Cash from Operations -0.34
Cash from Investing 0.00
Cash from Financing 0.33
Net change in Cash 0.00
Free Cash Flow -0.33
Particulars MAR 2021 (Values in Cr)
Net Income -0.95
Cash from Operations 0.73
Cash from Investing 0.00
Cash from Financing -0.93
Net change in Cash -0.17
Free Cash Flow 0.73
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.89 13.02 1.74 244.38 30.00 / 68.85
BLISS GVS PHARMA LTD 153.20 15.17 1.53 1617.36 105.05 / 190.65
CIPLA LTD 1560.90 23.38 4.04 126082.33 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 345.20 9.72 2.80 1015.96 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2863.80 51.23 24.86 48514.50 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.89 17.33 5.03 244.38 30.00 / 68.85
AMRUTAJAN HEALTH LTD 750.80 39.81 6.64 2170.61 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9065.70 107.17 29.42 22664.25 6222.35 / 10653.05
BLISS GVS PHARMA LTD 153.20 22.90 1.52 1617.36 105.05 / 190.65

HINDUSTAN BIO SCIENCES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
8.17 -0.12 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 8.00
  • 26 Days 8.30
  • 10 Days 8.10
  • 50 Days 8.50
  • 12 Days 8.10
  • 100 Days 8.60
  • 20 Days 8.20
  • 200 Days 8.80
8.06 PIVOT

First Support

7.94

First Resistance

8.30

Second Support

7.70

Second Resistance

8.42

Third Support

7.58

Third Resistance

8.66

RSI

47.20

ADX

32.78

MACD

-0.19

Williams % R

-43.70

Commodity Channel Index (CCI)

-60.31

Date

2025-09-11

Week

6515.00

Same Day

7916.00

Month

3507.00

1 Year

0.15

3 Year

0.21

Over 1 Month

-3.99%

down

Over 1 Year

-9.11%

down

Over 3 Months

-12.13%

down

Over 3 Years

32.08%

down

Over 6 Months

-0.24%

down

Over 5 Years

23.21%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

HINDUSTAN BIO SCIENCES LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
87.8%
Promoter Holdings
12.19%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Venkata Rama Mohan Raju Jampana 962091.0 (9.39%) Shareholding of Promoter and Promoter Group
Super Solutions India Private Limited 284815.0 (2.78%) Shareholding of Promoter and Promoter Group
Satyasai Kolli 265764.0 (2.59%) Public Shareholding
Vandana Yogesh Bhosale 169250.0 (1.65%) Public Shareholding
Madhusudan Rao Polineni 164600.0 (1.61%) Public Shareholding
Emily Bosco Menezes 158000.0 (1.54%) Public Shareholding
Chintalapati Deepika 140849.0 (1.37%) Public Shareholding
Danlaw Systems India Ltd 133732.0 (1.3%) Public Shareholding
Bosco Armando Menezes 111000.0 (1.08%) Public Shareholding
J Varun Varma 2100.0 (0.02%) Shareholding of Promoter and Promoter Group
J Uma 600.0 (0.01%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

HINDUSTAN BIO SCIENCES LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

HINDUSTAN BIO SCIENCES LTD. Share Price

Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991. The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates.

Previously, it was engaged in cement manufacturing and due to sluggish in the industry the company diversified its business into Bio Technology & Pharmaceuticals activities and the name of the Company was changed from Garuda Cements to Hindustan Bio-Sciences Ltd. In 2001, it diversified into software field and subsequently changed its name to Hindustan Softel Limited which presently got changed into Hindustan Bio Sciences Ltd.

The Company acquired the shares of Venkar Chemicals Ltd in 2004 and consequently upon acquisition, it became Wholly owned subsidiary of the Company with effect from 19.08.2004.

During 2006-07, Company got approval from Drugs Controller General of India (DCGI) and started marketing the nephrology product 'Recombinant Human Erythropoietin' with the brand name 'EPOVIN' from June, 2007.

The Company to its credit has world class manufacturing facilities for dry and liquid injectables, liquid/dry syrups, Eye/Ear/Nasal drops, pre-filled syringes and non sterile/sterile ointments, tablets and capsules approved by several regulatory authorities and is trusted by healthcare professionals and patients across the globe. Presently, it is now manufacturing and marketing finished dosage forms of pharmaceutical products.

Parent organization Indian Private
NSE symbol [-]
Founded 1991
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Hindustan Bio Sciences Ltd?

Answer Field

Hindustan Bio Sciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 8.17 as on Sep 12 2025 03:15 PM.

What is the Market Cap of Hindustan Bio Sciences Ltd Share?

Answer Field

The market cap of Hindustan Bio Sciences Ltd for NSE ₹ 0.00 & for BSE ₹ 8.40 as on Sep 12 2025 03:15 PM.

What is the 52 Week High and Low of Hindustan Bio Sciences Ltd?

Answer Field

The 52 Week High and Low of Hindustan Bio Sciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 13.47 and ₹ 6.70.

What is 1 year return for Hindustan Bio Sciences Ltd?

Answer Field

The 1 year returns on the stock has been -9.11%.

What is the P/E Ratio of Hindustan Bio Sciences Ltd Share?

Answer Field

As on Sep 12 2025 03:15 PM the price-to-earnings (PE) ratio for Hindustan Bio Sciences Ltd share is 272.67.

What is the PB ratio of Hindustan Bio Sciences Ltd Share?

Answer Field

As on Sep 12 2025 03:15 PM, the price-to-book (PB) ratio for Hindustan Bio Sciences Ltd share is 0.88.

How to Buy Hindustan Bio Sciences Ltd Share?

Answer Field

You can trade in Hindustan Bio Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Hindustan Bio Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Hindustan Bio Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Hindustan Bio Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91